IndustryPayments
Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

FATMA AISHA AHMOUDA

Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Psychiatric/Mental Health

NPI
1982311718
CMS profile
11412085
Location
COLUMBIA, MO

General Payments · PY2022–2024

$1,037.39

  • Reported across 60 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$842.03

54 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

Related groups: Psychiatric/Mental Health MO All categories

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $842.03 54

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
ITI, Inc. $226.34 13
Neurocrine BioSciences, Inc. $167.24 11
Alkermes, Inc. $158.66 15
ABBVIE INC. $88.43 5
Otsuka America Pharmaceutical, Inc. $79.12 3
Janssen Pharmaceuticals, Inc $63.11 4
Lundbeck LLC $45.93 2
Teva Pharmaceuticals USA, Inc. $13.20 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2022 $41.38 3
PY2023 $153.98 3
PY2024 $842.03 54

Payment records · PY2024 (54)

Sorted by paying entity, then date · as published by CMS

Program year 2024 20222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $14.56 08/09/2024 Food and Beverage Undisputed 01/23/2026 1106418494 CMS
ABBVIE INC. $25.13 08/26/2024 Food and Beverage Undisputed 01/23/2026 1106418496 CMS
ABBVIE INC. $18.76 10/28/2024 Food and Beverage Undisputed 01/23/2026 1106418498 CMS
ABBVIE INC. $16.46 11/14/2024 Food and Beverage Undisputed 01/23/2026 1106418500 CMS
ABBVIE INC. $13.52 12/09/2024 Food and Beverage Undisputed 01/23/2026 1106418502 CMS
Alkermes, Inc. $0.74 07/15/2024 Food and Beverage Undisputed 01/23/2026 1120455002 CMS
Alkermes, Inc. $19.20 08/08/2024 Food and Beverage Undisputed 01/23/2026 1120455004 CMS
Alkermes, Inc. $1.72 08/19/2024 Food and Beverage Undisputed 01/23/2026 1120455006 CMS
Alkermes, Inc. $5.53 08/19/2024 Food and Beverage Undisputed 01/23/2026 1120455008 CMS
Alkermes, Inc. $19.89 08/21/2024 Food and Beverage Undisputed 01/23/2026 1120455010 CMS
Alkermes, Inc. $20.39 09/23/2024 Food and Beverage Undisputed 01/23/2026 1120455012 CMS
Alkermes, Inc. $19.45 10/01/2024 Food and Beverage Undisputed 01/23/2026 1120455014 CMS
Alkermes, Inc. $3.95 10/14/2024 Food and Beverage Undisputed 01/23/2026 1120455016 CMS
Alkermes, Inc. $4.59 10/14/2024 Food and Beverage Undisputed 01/23/2026 1120455018 CMS
Alkermes, Inc. $3.56 10/22/2024 Food and Beverage Undisputed 01/23/2026 1120455020 CMS
Alkermes, Inc. $13.49 10/22/2024 Food and Beverage Undisputed 01/23/2026 1120455022 CMS
Alkermes, Inc. $17.28 11/11/2024 Food and Beverage Undisputed 01/23/2026 1120455024 CMS
Alkermes, Inc. $2.71 11/12/2024 Food and Beverage Undisputed 01/23/2026 1120455026 CMS
Alkermes, Inc. $0.18 12/23/2024 Food and Beverage Undisputed 01/23/2026 1120455028 CMS
Alkermes, Inc. $25.98 12/23/2024 Food and Beverage Undisputed 01/23/2026 1120455030 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $1.45 07/23/2024 Food and Beverage Undisputed 01/23/2026 1143354416 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $10.52 07/23/2024 Food and Beverage Undisputed 01/23/2026 1143354420 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $18.80 08/05/2024 Food and Beverage Undisputed 01/23/2026 1143354423 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $6.87 08/15/2024 Food and Beverage Undisputed 01/23/2026 1143354427 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $16.53 08/20/2024 Food and Beverage Undisputed 01/23/2026 1143354430 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $15.64 09/10/2024 Food and Beverage Undisputed 01/23/2026 1143354434 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $11.58 09/17/2024 Food and Beverage Undisputed 01/23/2026 1143354438 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $18.17 10/21/2024 Food and Beverage Undisputed 01/23/2026 1143354442 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $4.64 11/18/2024 Food and Beverage Undisputed 01/23/2026 1143354445 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $12.31 11/19/2024 Food and Beverage Undisputed 01/23/2026 1143354449 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $70.30 11/21/2024 Food and Beverage Undisputed 01/23/2026 1143354452 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $21.41 12/10/2024 Food and Beverage Undisputed 01/23/2026 1143354456 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $18.12 12/16/2024 Food and Beverage Undisputed 01/23/2026 1143354460 CMS
Janssen Pharmaceuticals, Inc $15.10 07/24/2024 Food and Beverage Undisputed 01/23/2026 1078057438 CMS
Janssen Pharmaceuticals, Inc $16.92 08/08/2024 Food and Beverage Undisputed 01/23/2026 1078057252 CMS
Janssen Pharmaceuticals, Inc $17.61 08/22/2024 Food and Beverage Undisputed 01/23/2026 1078057292 CMS
Janssen Pharmaceuticals, Inc $13.48 11/21/2024 Food and Beverage Undisputed 01/23/2026 1078057346 CMS
Lundbeck LLC $21.03 10/16/2024 Food and Beverage Undisputed 01/23/2026 1145986342 CMS
Lundbeck LLC $24.90 12/05/2024 Food and Beverage Undisputed 01/23/2026 1145986344 CMS
Neurocrine Biosciences, Inc. $26.74 07/11/2024 Food and Beverage Undisputed 01/23/2026 1150948821 CMS
Neurocrine Biosciences, Inc. $15.17 08/19/2024 Food and Beverage Undisputed 01/23/2026 1151003257 CMS
Neurocrine Biosciences, Inc. $7.70 08/19/2024 Food and Beverage Undisputed 01/23/2026 1151017942 CMS
Neurocrine Biosciences, Inc. $22.33 09/10/2024 Food and Beverage Undisputed 01/23/2026 1150967839 CMS
Neurocrine Biosciences, Inc. $5.81 09/10/2024 Food and Beverage Undisputed 01/23/2026 1151022068 CMS
Neurocrine Biosciences, Inc. $29.61 10/14/2024 Food and Beverage Undisputed 01/23/2026 1150940454 CMS
Neurocrine Biosciences, Inc. $2.29 10/14/2024 Food and Beverage Undisputed 01/23/2026 1151027180 CMS
Neurocrine Biosciences, Inc. $17.73 11/13/2024 Food and Beverage Undisputed 01/23/2026 1150991290 CMS
Neurocrine Biosciences, Inc. $5.27 11/13/2024 Food and Beverage Undisputed 01/23/2026 1151023174 CMS
Neurocrine Biosciences, Inc. $26.85 12/02/2024 Food and Beverage Undisputed 01/23/2026 1150948345 CMS
Neurocrine Biosciences, Inc. $7.74 12/02/2024 Food and Beverage Undisputed 01/23/2026 1151017870 CMS
Otsuka America Pharmaceutical, Inc. $19.71 08/06/2024 Food and Beverage Undisputed 01/23/2026 1119012393 CMS
Otsuka America Pharmaceutical, Inc. $38.14 09/16/2024 Food and Beverage Undisputed 01/23/2026 1119012395 CMS
Otsuka America Pharmaceutical, Inc. $21.27 10/31/2024 Food and Beverage Undisputed 01/23/2026 1119012397 CMS
Teva Pharmaceuticals USA, Inc. $13.20 09/25/2024 Food and Beverage Undisputed 01/23/2026 1151654193 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.